Vedanta Biosciences

Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. Vedanta Biosciences’ proprietary approach leverages foundational discoveries in the field of mucosal immunology to generate safe and potent treatments that restore intestinal homeostasis acting via mechanisms that are orthogonal to all existing drug classes. By modulating the microbiome with this class of drugs, we have the opportunity to treat a range of autoimmune and inflammatory diseases in potentially new ways and impact the lives of patients.
Company Growth (employees)
Cambridge, US
Size (employees)
43 (est)+3%
Vedanta Biosciences was founded in 2010 and is headquartered in Cambridge, US

Vedanta Biosciences Office Locations

Vedanta Biosciences has an office in Cambridge
Cambridge, US (HQ)
19 Blackstone St
Show all (1)

Vedanta Biosciences Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$50 m

Latest funding size

$50 m

Time since last funding

over 1 year


Vedanta Biosciences's latest funding round in June 2016 was reported to be $50 m. In total, Vedanta Biosciences has raised $50 m

Vedanta Biosciences's Web-traffic and Trends

Vedanta Biosciences Online and Social Media Presence

Vedanta Biosciences Company Life and Culture

You may also be interested in